Search | Page 18 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Allo HSCT Using RIC for Hematological Diseases

    ... regimen followed by a related or unrelated donor stem cell infusion. The primary objective is to evaluate rates of acute ... Blood Stem Cells On day 0, patients will receive an allogeneic transplant using PBSC which are CD34+ selected as the donor graft. ...

    Clinical Trial last updated 05/02/2016 - 9:29am.

  2. Clinical Trials Report for May 2015

    ... engraftment with CD3+ /CD19+ depleted peripheral stem cell grafts from mismatched donors. There are two conditioning regimens ... a Conventional 10/10 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant This is a pilot study ...

    Page last updated 04/28/2015 - 11:38am.

  3. Clinical Trials Report for July 2015

    ... engraftment with CD3+ /CD19+ depleted peripheral stem cell grafts from mismatched donors. There are two conditioning regimens ... a Conventional 10/10 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant This is a pilot study ...

    Page last updated 06/24/2015 - 1:43pm.

  4. Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic Anemia

    ... and disease free survival of 85% to 100%, can be obtained in allogeneic blood or bone marrow stem cell transplantation using an human leukocyte antigen ( HLA ...

    Clinical Trial last updated 04/08/2016 - 11:25pm.

  5. Pediatric MDS

    ... fi rst spotted as cytopenias (low blood counts). It’s a stem cell disorder in the bone marrow that results in disturbances  in ... approach on the pediatric side is to take the patient to an allogeneic bone marrow transplant as soon as possible because it’s a ...

    Interview last updated 10/24/2012 - 1:31pm.

  6. Interviews with the Experts MDS Genomics: Providing ‘Street View’ Directions of Disease

    ... to toxins or as a normal consequence of aging. If a blood stem cell suffers DNA damage involving a gene important for blood production, ... disease and may call for more aggressive treatment such as allogeneic hematopoietic cell transplant. What specific advantages are there ...

    Interview last updated 09/23/2014 - 9:30am.